Prognostic and clinicopathological significance of survivin in gynecological cancer
Agapiti H. Chuwa, David H. Mvunta · 2024
Read Prognostic and clinicopathological significance of survivin in gynecological cancer by Agapiti H. Chuwa, David H. Mvunta (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11646728.txt.
Description
Agapiti Chuwa and David Mvunta review survivin as a marker in women's cancers in a 2024 paper. Survivin blocks cell death and aids cell division. Tumors often switch it on while healthy tissue barely shows it. The review gathers what that means across gynecological cancers.
In womb cancer, high survivin tracks with worse survival. Ovarian tumors abound in it while benign tissue lacks it. In cervical disease, it flags precancer and virus risk, and hints at clearance chances. Signaling webs around the protein explain its reach, from growth pathways to oxygen sensing. The authors weigh survivin as both a prognosis gauge and a drug target.
Catalog record
| CREATOR | Agapiti H. Chuwa, David H. Mvunta |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |